NovoCure (NVCR) Gross Profit (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22% |
| Dec 31, 2025 | 7.93% |
| Sep 30, 2025 | 4.38% |
| Jun 30, 2025 | 0.74% |
| Mar 31, 2025 | -8.86% |
| Dec 31, 2024 | 6.75% |
| Sep 30, 2024 | 3.48% |
| Jun 30, 2024 | 10.39% |
| Mar 31, 2024 | 3.54% |
| Dec 31, 2023 | 6.30% |
| Sep 30, 2023 | 3.47% |
| Jun 30, 2023 | -0.58% |
| Mar 31, 2023 | -7.01% |
| Dec 31, 2022 | -1.69% |
| Sep 30, 2022 | -9.89% |
| Jun 30, 2022 | 2.32% |
| Mar 31, 2022 | 6.08% |
| Dec 31, 2021 | 0.12% |
| Sep 30, 2021 | -1.45% |
| Jun 30, 2021 | -3.13% |
| Mar 31, 2021 | -6.48% |
| Dec 31, 2020 | 11.08% |
| Sep 30, 2020 | 15.27% |
| Jun 30, 2020 | 16.96% |
| Mar 31, 2020 | 3.87% |
| Dec 31, 2019 | 7.64% |
| Sep 30, 2019 | 5.42% |
| Jun 30, 2019 | 22.64% |
| Mar 31, 2019 | 14.68% |
| Dec 31, 2018 | 1.83% |
| Sep 30, 2018 | 9.90% |
| Jun 30, 2018 | 23.00% |
| Mar 31, 2018 | -10.87% |
| Dec 31, 2017 | 8.77% |
| Sep 30, 2017 | 38.58% |
| Jun 30, 2017 | 8.65% |
| Mar 31, 2017 | 20.49% |
| Dec 31, 2016 | 82.53% |
| Sep 30, 2016 | 517.31% |
| Jun 30, 2016 | -66.28% |
| Mar 31, 2016 | -16.58% |
| Dec 31, 2015 | 84.55% |
| Sep 30, 2015 | 83.71% |
| Jun 30, 2015 | 36.77% |
| Mar 31, 2015 | 11.96% |
| Dec 31, 2014 | -34.51% |